Optimized protocol for amyloid-β extraction from the brain

Journal of Alzheimer's Disease

Volumn 34, Issue 4, 2013, Pages 835-839

  Izco, María ^a   Pesini, Pedro ^a,b   Pérez Grijalba, Virginia ^a   Fandos, Noelia ^b   Sarasa, Manuel ^a,b  

^a CENTER FOR BIOMEDICAL RESEARCH OF LA RIOJA CIBIR   (Spain)

^b R and D Department   (Spain)

Author keywords

Alzheimer's disease; amyloid peptides; animal models; ELISA; tissue extraction; tissue homogenization

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; AMYLOID BETA PROTEIN BRAIN LEVEL; AMYLOID PLAQUE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; BRAIN LEVEL; BRAIN TISSUE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACTION; LIMIT OF QUANTITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXTRACTION; SUPERNATANT;

EID: 84876383957     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-121798     Document Type: Article

References (12)

1. Cao D, Lu H, Lewis TL, Li L (2007) Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer's disease. J Biol Chem 282, 36275-36282.
2. Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Hsiao K, Younkin SG (2001) Age-dependent changes in brain, CSF and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 21, 372-381. (Pubitemid 32107428)
3. Schmidt SD, Jiang Y, Nixon RA, Mathews PM (2005) Tissue processing prior to protein analysis and amyloid-β quantitation. Methods Mol Biol 299, 267-278.
4. Schmidt SD, Ralph A, Mathews N, Mathews PM (2012) Tissue processing prior to analysis of Alzheimer's disease associated proteins and metabolites, including Aβ. Methods Mol Biol 849, 493-506.
5. Shankar GM, Li S, Mehta TH, Garcia-Muñoz A, Shepardson NE, Smith I, Brett FM, Farrel MA, Rowan MJ, Lemera CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14, 837-842.
6. Harigaya Y, Shoji M, Kawarabayashi T, Kanai M, Nakamura T, Lizuka T, Igeta Y, Saido TC, Sahara N, Mori H, Hirai S (1995) Modified amyloid β protein ending at 42 or 40 with different solubility accumulates in the brain of Alzheimer's disease. Biochem Biophys Res Commun 211, 1015-1022.
7. Hartman RE, Izumi Y, Bales RK, Paul SM, Wozniak DF, Holtzman DM (2005) Treatment with an amyloid-β antibody ameliorates plaque load, learning deficits, and hippocampal long-term potentiation in a mouse model of Alzheimer's disease. J Neurosci 25, 6213-6220. (Pubitemid 40923488)
8. Janus C, Pearson J, McLaurin JA, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount TJ, Nixon RA, Mercken M, Bergeron C, Fraser PE, St George-Hyslop P, Westaway D (2000) Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408, 979-982. (Pubitemid 32101644)
9. Kotilinek LA, Bacskai B, Westerman M, Kawarabayashi T, Younkin L, Hyman BT, Younkin S, Ashe KH (2002) Reversible memory loss in a mouse transgenic model of Alzheimer's disease. J Neurosci 22, 6331-6335. (Pubitemid 35386387)
10. Levites Y, Smithson LA, Price RW, Dakin RS, Yuan B, Sierks MR, Kim J, McGowan E, Kim Reed D, Rosenberry TL, Das P, Golde TE (2006) Insights into the mechanisms of action of anti-Aβ antibodies in Alzheimer's disease mouse models. FASEB J 20, E2002-E2014. (Pubitemid 44953785)
11. Sigurdsson EM, Knudsen E, Asuni A, Fitzer-Attas C, Sage D, Quartermain D, Goni F, Frangione B, Wisniewski T (2004) An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-β derivatives. J Neurosci 24, 6277-6282. (Pubitemid 38944217)
12. Pesini P, Pérez-Grijalba V, Monleón I, Boada M, Tárraga L, Martínez-Lage P, San-José I, Sarasa M (2012) Reliable measurements of the β-amyloid pool in blood could help in the early diagnosis of AD. Int J Alzheimers Dis 2012, 604141.